Username


Password

Preview

Maurizio Bifulco

Publications

  • TOP 3
  • Clementina Manera; Giuseppe Saccomanni; Anna Maria Malfitano; Simone Bertini; Francesca Castelli; Chiara Laezza; Alessia Ligresti; Valentina Lucchesi; Tiziano Tuccinardi; Flavio Rizzolio; et al.
    Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold.
  • Anna Maria Malfitano; Chiara Laezza; Mario Galgani; Giuseppe Matarese; Alba D'Alessandro; Patrizia Gazzerro; Maurizio Bifulco
    The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.
  • Maria C Proto; Patrizia Gazzerro; Luciano Di Croce; Antonietta Santoro; Anna M Malfitano; Simona Pisanti; Chiara Laezza; Maurizio Bifulco
    Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth.
Register to see all publications

Register for free to view:

Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the research activity
of experts around the globe
Register to see more

Geonetwork of Maurizio Bifulco (preview)

  • Cities where this author has publications
  • Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

  • 2012: Clementina Manera; Giuseppe Saccomanni; Anna Maria Malfitano; Simone Bertini; Francesca Castelli; Chiara Laezza; Alessia Ligresti; Valentina Lucchesi; Tiziano Tuccinardi; Flavio Rizzolio; et al.
    Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: An investigation of the 1,8-naphthyridin-2(1H)-one scaffold.
    European journal of medicinal chemistry 2012;52():284-94.
  • 2012: Anna Maria Malfitano; Chiara Laezza; Mario Galgani; Giuseppe Matarese; Alba D'Alessandro; Patrizia Gazzerro; Maurizio Bifulco
    The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice.
    Pharmacological research : the official journal of the Italian Pharmacological Society 2012;65(3):365-71.
  • 2012: Maria C Proto; Patrizia Gazzerro; Luciano Di Croce; Antonietta Santoro; Anna M Malfitano; Simona Pisanti; Chiara Laezza; Maurizio Bifulco
    Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth.
    Journal of cellular physiology 2012;227(1):250-8.
  • 2011: Lucia Prota; Antonietta Santoro; Maurizio Bifulco; Rita P Aquino; Teresa Mencherini; Paola Russo
    Leucine enhances aerosol performance of naringin dry powder and its activity on cystic fibrosis airway epithelial cells.
    International journal of pharmaceutics 2011;412(1-2):8-19.
  • 2011: Simona Pisanti; Paola Picardi; Lucia Prota; Maria Chiara Proto; Chiara Laezza; Paul G McGuire; Lucia Morbidelli; Patrizia Gazzerro; Marina Ziche; Arup Das; et al.
    Genetic and pharmacologic inactivation of cannabinoid CB1 receptor inhibits angiogenesis.
    Blood 2011;117(20):5541-50.
  • 2011: Anna Maria Malfitano; Elena Ciaglia; Giuseppina Gangemi; Patrizia Gazzerro; Chiara Laezza; Maurizio Bifulco
    Update on the endocannabinoid system as an anticancer target.
    Expert opinion on therapeutic targets 2011;15(3):297-308.
  • 2011: Anna Maria Malfitano; Silvio Sosa; Chiara Laezza; Marco De Bortoli; Aurelia Tubaro; Maurizio Bifulco
    Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice.
    British journal of pharmacology 2011;162(1):84-93.
  • 2010: Mario Scrima; Sara Di Marino; Manuela Grimaldi; Antonia Mastrogiacomo; Ettore Novellino; Maurizio Bifulco; Anna Maria D'Ursi
    Binding of the hemopressin peptide to the cannabinoid CB1 receptor: structural insights.
    Biochemistry 2010;49(49):10449-57.
  • 2010: Chiara Laezza; Anna M Malfitano; Tiziana Di Matola; Paolo Ricchi; Maurizio Bifulco
    Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells.
    Molecular carcinogenesis 2010;49(10):892-901.
  • 2010: Dario Gallotta; Patrizia Nigro; Roberta Cotugno; Patrizia Gazzerro; Maurizio Bifulco; Maria Antonietta Belisario
    Rimonabant-induced apoptosis in leukemia cell lines: activation of caspase-dependent and -independent pathways.
    Biochemical pharmacology 2010;80(3):370-80.
  • 2010: Michele Linsalata; Maria Notarnicola; Valeria Tutino; Maurizio Bifulco; Antonietta Santoro; Chiara Laezza; Caterina Messa; Antonella Orlando; Maria Gabriella Caruso
    Effects of anandamide on polyamine levels and cell growth in human colon cancer cells.
    Anticancer research 2010;30(7):2583-9.
  • 2010: Chiara Laezza; Anna Maria Malfitano; Maria Chiara Proto; Iolanda Esposito; Patrizia Gazzerro; Pietro Formisano; Simona Pisanti; Antonietta Santoro; Maria Gabriella Caruso; Maurizio Bifulco
    Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells.
    Endocrine-related cancer 2010;17(2):495-503.
  • 2010: Palmiero Monteleone; Maurizio Bifulco; Giuseppe Maina; Alfonso Tortorella; Patrizia Gazzerro; Maria Chiara Proto; Carmela Di Filippo; Francesco Monteleone; Benedetta Canestrelli; Giovanna Buonerba; et al.
    Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression.
    Pharmacological research : the official journal of the Italian Pharmacological Society 2010;61(5):400-4.
  • 2010: Rosanna Cozzolino; Gaetano Calì; Maurizio Bifulco; Paolo Laccetti
    A metabolically stable analogue of anandamide, Met-F-AEA, inhibits human thyroid carcinoma cell lines by activation of apoptosis.
    Investigational new drugs 2010;28(2):115-23.
  • 2010: Patrizia Gazzerro; Anna M Malfitano; Maria Chiara Proto; Antonietta Santoro; Simona Pisanti; Maria Gabriella Caruso; Maria Notarnicola; Caterina Messa; Chiara Laezza; Gabriella Misso; et al.
    Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin.
    Oncology reports 2010;23(1):171-5.
  • 2009: P Monteleone; M Bifulco; C Di Filippo; P Gazzerro; B Canestrelli; F Monteleone; M C Proto; M Di Genio; C Grimaldi; M Maj
    Association of CNR1 and FAAH endocannabinoid gene polymorphisms with anorexia nervosa and bulimia nervosa: evidence for synergistic effects.
    Genes, brain, and behavior 2009;8(7):728-32.
  • 2009: Antonietta Santoro; Simona Pisanti; Claudia Grimaldi; Angelo A Izzo; Francesca Borrelli; Maria C Proto; Anna M Malfitano; Patrizia Gazzerro; Chiara Laezza; Maurizio Bifulco
    Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon.
    International journal of cancer. Journal international du cancer 2009;125(5):996-1003.
  • 2009: Simona Pisanti; Maurizio Bifulco
    Endocannabinoid system modulation in cancer biology and therapy.
    Pharmacological research : the official journal of the Italian Pharmacological Society 2009;60(2):107-16.
  • 2009: Angelyne Benavides; Assunta Napolitano; Carla Bassarello; Virginia Carbone; Patrizia Gazzerro; Annamaria Malfitano; Paola Saggese; Maurizio Bifulco; Sonia Piacente; Cosimo Pizza
    Oxylipins from Dracontium loretense.
    Journal of natural products 2009;72(5):813-7.
  • 2009: Chiara Laezza; Maria Gabriella Caruso; Teresa Gentile; Maria Notarnicola; Anna Maria Malfitano; Tiziana Di Matola; Caterina Messa; Patrizia Gazzerro; Maurizio Bifulco
    N6-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1.
    International journal of cancer. Journal international du cancer 2009;124(6):1322-9.
  • 2009: Simona Pisanti; Anna Maria Malfitano; Claudia Grimaldi; Antonietta Santoro; Patrizia Gazzerro; Chiara Laezza; Maurizio Bifulco
    Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.
    Best practice & research. Clinical endocrinology & metabolism 2009;23(1):117-31.
  • 2009: Maurizio Bifulco; Antonietta Santoro; Chiara Laezza; Anna Maria Malfitano
    Cannabinoid receptor CB1 antagonists state of the art and challenges.
    Vitamins and hormones 2009;81():159-89.
  • 2008: Maurizio Bifulco; Magda Marasco; Simona Pisanti
    Dietary recommendations in the medieval Medical School of Salerno: a lesson from the past.
    American journal of preventive medicine 2008;35(6):602-3.
  • 2008: Iolanda Esposito; Maria Chiara Proto; Patrizia Gazzerro; Chiara Laezza; Claudia Miele; Anna Teresa Alberobello; Vittoria D'Esposito; Francesco Beguinot; Pietro Formisano; Maurizio Bifulco
    The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase.
    Molecular pharmacology 2008;74(6):1678-86.
  • 2008: Chiara Laezza; Laura Fiorentino; Simona Pisanti; Patrizia Gazzerro; Michele Caraglia; Giuseppe Portella; Mario Vitale; Maurizio Bifulco
    Lovastatin induces apoptosis of k-ras-transformed thyroid cells via inhibition of ras farnesylation and by modulating redox state.
    Journal of molecular medicine (Berlin, Germany) 2008;86(12):1341-51.
  • 2008: Chiara Laezza; Simona Pisanti; Anna Maria Malfitano; Maurizio Bifulco
    The anandamide analog, Met-F-AEA, controls human breast cancer cell migration via the RHOA/RHO kinase signaling pathway.
    Endocrine-related cancer 2008;15(4):965-74.
  • 2008: Anna Maria Malfitano; Maria Chiara Proto; Maurizio Bifulco
    Cannabinoids in the management of spasticity associated with multiple sclerosis.
    Neuropsychiatric disease and treatment 2008;4(5):847-53.
  • 2008: Antonietta Santoro; Patrizia Gazzerro; Anna Maria Malfitano; Simona Pisanti; Chiara Laezza; Maurizio Bifulco
    Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer".
    International journal of cancer. Journal international du cancer 2008;123(1):243-4.
  • 2008: Maurizio Bifulco; Anna Maria Malfitano; Simona Pisanti; Chiara Laezza
    Endocannabinoids in endocrine and related tumours.
    Endocrine-related cancer 2008;15(2):391-408.
  • 2008: Antonietta Santoro; Giuseppe Bianco; Patrizia Picerno; Rita Patrizia Aquino; Giuseppina Autore; Stefania Marzocco; Patrizia Gazzerro; Maria Brigida Lioi; Maurizio Bifulco
    Verminoside- and verbascoside-induced genotoxicity on human lymphocytes: involvement of PARP-1 and p53 proteins.
    Toxicology letters 2008;178(2):71-6.
  • 2008: Maurizio Bifulco; Anna Maria Malfitano; Giuseppe Marasco
    Potential therapeutic role of statins in neurological disorders.
    Expert review of neurotherapeutics 2008;8(5):827-37.
  • 2008: Maurizio Bifulco
    Therapeutic potential of statins in thyroid proliferative disease.
    Nature clinical practice. Endocrinology & metabolism 2008;4(5):242-3.
  • 2008: A M Malfitano; C Laezza; S Pisanti; P Gazzerro; M Bifulco
    Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells.
    British journal of pharmacology 2008;153(5):1003-10.
  • 2008: Maurizio Bifulco; Anna Maria Malfitano; Maria Chiara Proto; Antonietta Santoro; Maria Gabriella Caruso; Chiara Laezza
    Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug.
    Anti-cancer agents in medicinal chemistry 2008;8(2):200-4.
  • 2008: Cinzia Esposito; Mario Scrima; Alfonso Carotenuto; Annamaria Tedeschi; Paolo Rovero; Gerardino D'Errico; Anna Maria Malfitano; Maurizio Bifulco; Anna Maria D'Ursi
    Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2',3'-cyclic nucleotide-3'-phosphodiesterase.
    Biochemistry 2008;47(1):308-19.
  • 2008: Maria Notarnicola; Caterina Messa; Antonella Orlando; Maurizio Bifulco; Chiara Laezza; Patrizia Gazzerro; Maria Gabriella Caruso
    Estrogenic induction of cannabinoid CB1 receptor in human colon cancer cell lines.
    Scandinavian journal of gastroenterology 2008;43(1):66-72.
  • 2008: Maurizio Bifulco
    In memory of Nino Salvatore: tenth anniversary.
    Thyroid : official journal of the American Thyroid Association 2008;18(1):91-2.
  • 2007: Maurizio Bifulco; Maria Gabriella Caruso
    From the gastronomic revolution to the new globesity epidemic.
    Journal of the American Dietetic Association 2007;107(12):2058-60.
  • 2007: Stefania Stingo; Mariorosario Masullo; Eugenia Polverini; Chiara Laezza; Immacolata Ruggiero; Rosaria Arcone; Enrica Ruozi; Fabrizio Dal Piaz; Anna Maria Malfitano; Anna Maria D'Ursi; et al.
    The N-terminal domain of 2',3'-cyclic nucleotide 3'-phosphodiesterase harbors a GTP/ATP binding site.
    Chemical biology & drug design 2007;70(6):502-10.
  • 2007: Silvana Libertini; Irma Iacuzzo; Angelo Ferraro; Mario Vitale; Maurizio Bifulco; Alfredo Fusco; Giuseppe Portella
    Lovastatin enhances the replication of the oncolytic adenovirus dl1520 and its antineoplastic activity against anaplastic thyroid carcinoma cells.
    Endocrinology 2007;148(11):5186-94.
  • 2007: F Minutolo; M G Cascio; I Carboni; T Bisogno; G Prota; S Bertini; M Digiacomo; M Bifulco; V Di Marzo; M Macchia
    Metabolically labile cannabinoid esters: a 'soft drug' approach for the development of cannabinoid-based therapeutic drugs.
    Bioorganic & medicinal chemistry letters 2007;17(17):4878-81.
  • 2007: Maurizio Bifulco; Claudia Grimaldi; Patrizia Gazzerro; Simona Pisanti; Antonietta Santoro
    Rimonabant: just an antiobesity drug? Current evidence on its pleiotropic effects.
    Molecular pharmacology 2007;71(6):1445-56.
  • 2007: P Gazzerro; M G Caruso; M Notarnicola; G Misciagna; V Guerra; C Laezza; M Bifulco
    Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population.
    International journal of obesity (2005) 2007;31(6):908-12.
  • 2007: Simona Pisanti; Cristina Borselli; Olimpia Oliviero; Chiara Laezza; Patrizia Gazzerro; Maurizio Bifulco
    Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy.
    Journal of cellular physiology 2007;211(2):495-503.
  • 2007: Anna Maria Malfitano; Gokce Altay Toruner; Patrizia Gazzerro; Chiara Laezza; Seema Husain; Davide Eletto; Pierangelo Orlando; Luciano De Petrocellis; Alexandra Terskiy; Marvin Schwalb; et al.
    Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells.
    Immunology letters 2007;109(2):145-54.
  • 2007: Maurizio Bifulco; Chiara Laezza; Patrizia Gazzerro; Francesca Pentimalli
    Endocannabinoids as emerging suppressors of angiogenesis and tumor invasion (review).
    Oncology reports 2007;17(4):813-6.
  • 2007: M Bifulco; C Laezza; A M Malfitano
    From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches.
    Multiple sclerosis (Houndmills, Basingstoke, England) 2007;13(1):133-4.
  • 2007: Maurizio Bifulco; Paolo Cavallo
    Thyroidology in the medieval Medical School of Salerno.
    Thyroid : official journal of the American Thyroid Association 2007;17(1):39-40.
  • 2006: Chiara Laezza; Simona Pisanti; Elvira Crescenzi; Maurizio Bifulco
    Anandamide inhibits Cdk2 and activates Chk1 leading to cell cycle arrest in human breast cancer cells.
    FEBS letters 2006;580(26):6076-82.
  • 2006: Chiara Laezza; Gherardo Mazziotti; Laura Fiorentino; Patrizia Gazzerro; Giuseppe Portella; Diego Gerbasio; Carlo Carella; Giuseppe Matarese; Maurizio Bifulco
    HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway.
    Journal of molecular medicine (Berlin, Germany) 2006;84(11):967-73.
  • 2006: Daniela Sarnataro; Simona Pisanti; Antonietta Santoro; Patrizia Gazzerro; Anna Maria Malfitano; Chiara Laezza; Maurizio Bifulco
    The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanism.
    Molecular pharmacology 2006;70(4):1298-306.
  • 2006: Alessia Ligresti; Aniello Schiano Moriello; Katarzyna Starowicz; Isabel Matias; Simona Pisanti; Luciano De Petrocellis; Chiara Laezza; Giuseppe Portella; Maurizio Bifulco; Vincenzo Di Marzo
    Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
    The Journal of pharmacology and experimental therapeutics 2006;318(3):1375-87.
  • 2006: Maurizio Bifulco; Chiara Laezza; Simona Pisanti; Patrizia Gazzerro
    Cannabinoids and cancer: pros and cons of an antitumour strategy.
    British journal of pharmacology 2006;148(2):123-35.
  • 2006: Chiara Laezza; Maria Notarnicola; Maria Gabriella Caruso; Caterina Messa; Marco Macchia; Simone Bertini; Filippo Minutolo; Giuseppe Portella; Laura Fiorentino; Stefania Stingo; et al.
    N6-isopentenyladenosine arrests tumor cell proliferation by inhibiting farnesyl diphosphate synthase and protein prenylation.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2006;20(3):412-8.
  • 2006: Claudia Grimaldi; Simona Pisanti; Chiara Laezza; Anna Maria Malfitano; Antonietta Santoro; Mario Vitale; Maria Gabriella Caruso; Maria Notarnicola; Irma Iacuzzo; Giuseppe Portella; et al.
    Anandamide inhibits adhesion and migration of breast cancer cells.
    Experimental cell research 2006;312(4):363-73.
  • 2006: Anna Maria Malfitano; Rachel Cahill; Peter Mitchell; Gad Frankel; Gordon Dougan; Maurizio Bifulco; Giovanna Lombardi; Robert I Lechler; Kathleen B Bamford
    Helicobacter pylori has stimulatory effects on naive T cells.
    Helicobacter 2006;11(1):21-30.
  • 2006: Anna Maria Malfitano; Giuseppe Matarese; Simona Pisanti; Claudia Grimaldi; Chiara Laezza; Tiziana Bisogno; Vincenzo Di Marzo; Robert I Lechler; Maurizio Bifulco
    Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis.
    Journal of neuroimmunology 2006;171(1-2):110-9.
  • 2006: Maria Notarnicola; Donato Francesco Altomare; Menotti Calvani; Antonella Orlando; Maurizio Bifulco; Benedetta D'Attoma; Maria Gabriella Caruso
    Fatty acid synthase hyperactivation in human colorectal cancer: relationship with tumor side and sex.
    Oncology 2006;71(5-6):327-32.
  • 2005: Anna Maria Malfitano; Giuseppe Matarese; Maurizio Bifulco
    From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases.
    Current drug targets. CNS and neurological disorders 2005;4(6):667-75.
  • 2005: Caterina Messa; Maria Notarnicola; Francesco Russo; Aldo Cavallini; Valentina Pallottini; Anna Trentalance; Maurizio Bifulco; Chiara Laezza; Maria Gabriella Caruso
    Estrogenic regulation of cholesterol biosynthesis and cell growth in DLD-1 human colon cancer cells.
    Scandinavian journal of gastroenterology 2005;40(12):1454-61.
  • 2005: Daniela Sarnataro; Claudia Grimaldi; Simona Pisanti; Patrizia Gazzerro; Chiara Laezza; Chiara Zurzolo; Maurizio Bifulco
    Plasma membrane and lysosomal localization of CB1 cannabinoid receptor are dependent on lipid rafts and regulated by anandamide in human breast cancer cells.
    FEBS letters 2005;579(28):6343-9.
  • 2005: Maurizio Bifulco
    Role of the isoprenoid pathway in ras transforming activity, cytoskeleton organization, cell proliferation and apoptosis.
    Life sciences 2005;77(14):1740-9.
  • 2005: Davide Eletto; Arturo Leone; Maurizio Bifulco; Mario F Tecce
    Effect of unsaturated fat intake from Mediterranean diet on rat liver mRNA expression profile: selective modulation of genes involved in lipid metabolism.
    Nutrition, metabolism, and cardiovascular diseases : NMCD 2005;15(1):13-23.
  • 2004: Maurizio Bifulco; Chiara Laezza; Marta Valenti; Alessia Ligresti; Giuseppe Portella; Vincenzo DI Marzo
    A new strategy to block tumor growth by inhibiting endocannabinoid inactivation.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2004;18(13):1606-8.
  • 2004: Gabriella Corea; Maria Iorizzi; Virginia Lanzotti; Maria Cammareri; Clara Conicella; Chiara Laezza; Maurizio Bifulco
    Astersedifolioside A-C, three new oleane-type saponins with antiproliferative activity.
    Bioorganic & medicinal chemistry 2004;12(18):4909-15.
  • 2004: Eva de Lago; Alessia Ligresti; Giorgio Ortar; Enrico Morera; Ana Cabranes; Gareth Pryce; Maurizio Bifulco; David Baker; Javier Fernandez-Ruiz; Vincenzo Di Marzo
    In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake.
    European journal of pharmacology 2004;484(2-3):249-57.
  • 2004: Maria Notarnicola; Caterina Messa; Aldo Cavallini; Maurizio Bifulco; Mario Felice Tecce; Davide Eletto; Alfredo Di Leo; Severino Montemurro; Chiara Laezza; Maria Gabriella Caruso
    Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis.
    Oncology 2004;67(5-6):351-8.
  • 2003: Giuseppe Portella; Chiara Laezza; Paolo Laccetti; Luciano De Petrocellis; Vincenzo Di Marzo; Maurizio Bifulco
    Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasis.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003;17(12):1771-3.
  • 2003: Alessia Ligresti; Tiziana Bisogno; Isabel Matias; Luciano De Petrocellis; Maria Grazia Cascio; Vittorio Cosenza; Giuseppe D'argenio; Giuseppe Scaglione; Maurizio Bifulco; Italo Sorrentini; et al.
    Possible endocannabinoid control of colorectal cancer growth.
    Gastroenterology 2003;125(3):677-87.
  • 2003: Selena Harrison; Luciano De Petrocellis; Marcello Trevisani; Francesca Benvenuti; Maurizio Bifulco; Pierangelo Geppetti; Vincenzo Di Marzo
    Capsaicin-like effects of N-arachidonoyl-dopamine in the isolated guinea pig bronchi and urinary bladder.
    European journal of pharmacology 2003;475(1-3):107-14.
  • 2003: Maurizio Bifulco; Vincenzo Di Marzo
    [The endocannabinoid system as a target for the development of new drugs for cancer therapy].
    Recenti progressi in medicina 2003;94(5):194-8.
  • 2003: M G Caruso; M Notarnicola; M Bifulco; C Laezza; V Guerra; D F Altomare; V Memeo; D Lorusso; I Demma; A Di Leo
    Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation.
    Scandinavian journal of gastroenterology 2003;38(1):80-5.
  • 2002: Luciano De Petrocellis; Tiziana Bisogno; Alessia Ligresti; Maurizio Bifulco; Dominique Melck; Vincenzo Di Marzo
    Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems.
    Fundamental & clinical pharmacology 2002;16(4):297-302.
  • 2002: Paolo Mondola; Rosalba Serù; Mariarosaria Santillo; Simona Damiano; Maurizio Bifulco; Chiara Laezza; Pietro Formisano; Giuseppe Rotilio; Maria Rosa Ciriolo
    Effect of Cu,Zn superoxide dismutase on cholesterol metabolism in human hepatocarcinoma (HepG2) cells.
    Biochemical and biophysical research communications 2002;295(3):603-9.
  • 2002: Maurizio Bifulco; Vincenzo Di Marzo
    Targeting the endocannabinoid system in cancer therapy: a call for further research.
    Nature medicine 2002;8(6):547-50.
  • 2002: Jason W Brooks; Gareth Pryce; Tiziana Bisogno; Siân I Jaggar; Deborah J R Hankey; Peter Brown; Daniel Bridges; Catherine Ledent; Maurizio Bifulco; Andrew S C Rice; et al.
    Arvanil-induced inhibition of spasticity and persistent pain: evidence for therapeutic sites of action different from the vanilloid VR1 receptor and cannabinoid CB(1)/CB(2) receptors.
    European journal of pharmacology 2002;439(1-3):83-92.
  • 2002: Giovanni Cuda; Roberto Paternò; Roberto Ceravolo; Mafalda Candigliota; Nicola Perrotti; Francesco Perticone; Maria Concetta Faniello; Filippo Schepis; Antonio Ruocco; Evelina Mele; et al.
    Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling.
    Circulation 2002;105(8):968-74.
  • 2002: Maurizio Bifulco; Chiara Laezza; Stefania Stingo; J Wolff
    2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin.
    Proceedings of the National Academy of Sciences of the United States of America 2002;99(4):1807-12.
  • 2001: M Bifulco; C Laezza; G Portella; M Vitale; P Orlando; L De Petrocellis; V Di Marzo
    Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(14):2745-7.
  • 2001: T Di Matola; F D'Ascoli; C Luongo; M Bifulco; G Rossi; G Fenzi; M Vitale
    Lovastatin-induced apoptosis in thyroid cells: involvement of cytochrome c and lamin B.
    European journal of endocrinology / European Federation of Endocrine Societies 2001;145(5):645-50.
  • 2001: V Di Marzo; D Melck; P Orlando; T Bisogno; O Zagoory; M Bifulco; Z Vogel; L De Petrocellis
    Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells.
    The Biochemical journal 2001;358(Pt 1):249-55.
  • 2000: V Di Marzo; M Bifulco; L De Petrocellis
    Endocannabinoids and multiple sclerosis: a blessing from the 'inner bliss'?
    Trends in pharmacological sciences 2000;21(6):195-7.
  • 2000: T Di Matola; F Mueller; G Fenzi; G Rossi; M Bifulco; L A Marzano; M Vitale
    Serum withdrawal-induced apoptosis in thyroid cells is caused by loss of fibronectin-integrin interaction.
    The Journal of clinical endocrinology and metabolism 2000;85(3):1188-93.
  • 2000: P Mondola; M Bifulco; R Serù; T Annella; M R Ciriolo; M Santillo
    Presence of CuZn superoxide dismutase in human serum lipoproteins.
    FEBS letters 2000;467(1):57-60.
  • 2000: D Melck; L De Petrocellis; P Orlando; T Bisogno; C Laezza; M Bifulco; V Di Marzo
    Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Endocrinology 2000;141(1):118-26.
  • 1999: M Santillo; A Migliaro; P Mondola; C Laezza; S Damiano; S Stingo; L Fiorentino; A Andreozzi; M Vitale; M Bifulco
    Dietary and hypothyroid hypercholesterolemia induces hepatic apolipoprotein E expression in the rat: direct role of cholesterol.
    FEBS letters 1999;463(1-2):83-6.
  • 1999: M Vitale; T Di Matola; M Bifulco; A Casamassima; G Fenzi; G Rossi
    Apoptosis induced by denied adhesion to extracellular matrix (anoikis) in thyroid epithelial cells is p53 dependent but fails to correlate with modulation of p53 expression.
    FEBS letters 1999;462(1-2):57-60.
  • 1999: D Melck; T Bisogno; L De Petrocellis; H Chuang; D Julius; M Bifulco; V Di Marzo
    Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors.
    Biochemical and biophysical research communications 1999;262(1):275-84.
  • 1999: M Bifulco; C Laezza; S M Aloj
    Inhibition of farnesylation blocks growth but not differentiation in FRTL-5 thyroid cells.
    Biochimie 1999;81(4):287-90.
  • 1999: M Paolillo; A Feliciello; A Porcellini; C Garbi; M Bifulco; S Schinelli; C Ventra; E Stabile; G Ricciardelli; G Schettini; et al.
    The type and the localization of cAMP-dependent protein kinase regulate transmission of cAMP signals to the nucleus in cortical and cerebellar granule cells.
    The Journal of biological chemistry 1999;274(10):6546-52.
  • 1999: M Vitale; T Di Matola; G Rossi; C Laezza; G Fenzi; M Bifulco
    Prenyltransferase inhibitors induce apoptosis in proliferating thyroid cells through a p53-independent CrmA-sensitive, and caspase-3-like protease-dependent mechanism.
    Endocrinology 1999;140(2):698-704.
  • 1998: C Laezza; V Di Marzo; M Bifulco
    v-K-ras leads to preferential farnesylation of p21(ras) in FRTL-5 cells: multiple interference with the isoprenoid pathway.
    Proceedings of the National Academy of Sciences of the United States of America 1998;95(23):13646-51.
  • 1998: C Laezza; C Bucci; M Santillo; C B Bruni; M Bifulco
    Control of Rab5 and Rab7 expression by the isoprenoid pathway.
    Biochemical and biophysical research communications 1998;248(3):469-72.
  • 1998: L De Petrocellis; D Melck; A Palmisano; T Bisogno; C Laezza; M Bifulco; V Di Marzo
    The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.
    Proceedings of the National Academy of Sciences of the United States of America 1998;95(14):8375-80.
  • 1998: C Bucci; R Serù; T Annella; R Vitelli; D Lattero; M Bifulco; P Mondola; M Santillo
    Free fatty acids modulate LDL receptor activity in BHK-21 cells.
    Atherosclerosis 1998;137(2):329-40.
  • 1997: C Laezza; J Wolff; M Bifulco
    Identification of a 48-kDa prenylated protein that associates with microtubules as 2',3'-cyclic nucleotide 3'-phosphodiesterase in FRTL-5 cells.
    FEBS letters 1997;413(2):260-4.
  • 1997: C Laezza; A Migliaro; R Cerbone; I Tedesco; M Santillo; C Garbi; M Bifulco
    N6-isopentenyladenosine affects cAMP-dependent microfilament organization in FRTL-5 thyroid cells.
    Experimental cell research 1997;234(1):178-82.
  • 1997: R Vitelli; M Santillo; D Lattero; M Chiariello; M Bifulco; C B Bruni; C Bucci
    Role of the small GTPase Rab7 in the late endocytic pathway.
    The Journal of biological chemistry 1997;272(7):4391-7.
  • 1996: M Santillo; P Mondola; A Gioielli; R Serù; S Iossa; T Annella; M Vitale; M Bifulco
    Inhibitors of Ras farnesylation revert the increased resistance to oxidative stress in K-Ras transformed NIH 3T3 cells.
    Biochemical and biophysical research communications 1996;229(3):739-45.
  • 1996: I M Bonapace; R Addeo; L Altucci; L Cicatiello; M Bifulco; C Laezza; S Salzano; V Sica; F Bresciani; A Weisz
    17 beta-Estradiol overcomes a G1 block induced by HMG-CoA reductase inhibitors and fosters cell cycle progression without inducing ERK-1 and -2 MAP kinases activation.
    Oncogene 1996;12(4):753-63.
  • 1996: M Santillo; P Mondola; A Milone; A Gioielli; M Bifulco
    Ascorbate administration to normal and cholesterol-fed rats inhibits in vitro TBARS formation in serum and liver homogenates.
    Life sciences 1996;58(14):1101-8.
  • 1995: B Perillo; I Tedesco; C Laezza; M Santillo; A Romano; S M Aloj; M Bifulco
    Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in FRTL-5 cells. II. Down-regulation by v-K-ras oncogene.
    The Journal of biological chemistry 1995;270(25):15237-41.
  • 1995: M Bifulco; B Perillo; M Saji; C Laezza; I Tedesco; L D Kohn; S M Aloj
    Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in FRTL-5 cells. I. Identification and characterization of a cyclic AMP-responsive element in the rat reductase promoter.
    The Journal of biological chemistry 1995;270(25):15231-6.
  • 1993: M Bifulco; C Laezza; S M Aloj; C Garbi
    Mevalonate controls cytoskeleton organization and cell morphology in thyroid epithelial cells.
    Journal of cellular physiology 1993;155(2):340-8.
  • 1992: P Mondola; M Santillo; F Santangelo; A Belfiore; P Gambardella; M Bifulco
    Effects of a new calf thymus protein on 3-hydroxy-3-methylglutaryl-CoA reductase activity in rat (Rattus bubalus) hepatocyte cells (BRL-3A).
    Comparative biochemistry and physiology. B, Comparative biochemistry 1992;103(2):431-4.
  • 1992: M Santillo; P Mondola; F Santangelo; A Belfiore; I Tedesco; C Laezza; R Cerbone; A Romano; M Bifulco
    Characterization of the low density lipoprotein receptor activity in buffalo rat liver (BRL-3A) cells.
    Comparative biochemistry and physiology. B, Comparative biochemistry 1992;101(3):489-94.
  • 1991: A Milone; M Delfino; A Piccirillo; G M Illiano; S M Aloj; M Bifulco
    Increased levels of DHEAS in serum of patients with X-linked ichthyosis.
    Journal of inherited metabolic disease 1991;14(1):96-104.
  • 1990: D Grieco; Z H Beg; A Romano; M Bifulco; S M Aloj
    Cell cycle progression and 3-hydroxy-3-methylglutaryl coenzyme A reductase are regulated by thyrotropin in FRTL-5 rat thyroid cells.
    The Journal of biological chemistry 1990;265(31):19343-50.
  • 1990: M Bifulco; M Santillo; I Tedesco; R Zarrilli; C Laezza; S M Aloj
    Thyrotropin modulates low density lipoprotein binding activity in FRTL-5 thyroid cells.
    The Journal of biological chemistry 1990;265(31):19336-42.
  • 1989: P Mondola; M Santillo; I Tedesco; F Santangelo; A Belfiore; M Bifulco
    Thymus fraction (FIII) effect on cholesterol metabolism: modulation of the low density lipoprotein receptor pathway.
    The International journal of biochemistry 1989;21(6):627-30.
  • 1989: P Mondola; M Santillo; F Santangelo; C Caporale; A Belfiore; M Bifulco
    Purification and characterization of a calf thymus protein active on lipid metabolism.
    The International journal of biochemistry 1989;21(9):1009-14.
  • 1988: C Garbi; C Zurzolo; M Bifulco; L Nitsch
    Synthesis of extracellular matrix glycoproteins by a differentiated thyroid epithelial cell line.
    Journal of cellular physiology 1988;135(1):39-46.
  • 1988: S M Aloj; F Beguinot; M Bifulco; L D Kohn
    Thyrotropin regulation of thyroid cell functions: mechanisms and relationship to thyroid disease.
    Annali dell'Istituto superiore di sanità 1988;24(1):117-27.
  • 1987: M Bifulco; I Spitz; H J Hirsch; J Shorer; S M Aloj
    High-molecular-weight serum thyrotropin revisited.
    The New England journal of medicine 1987;316(25):1609-10.
  • 1987: F Beguinot; L Beguinot; D Tramontano; C Duilio; S Formisano; M Bifulco; F S Ambesi-Impiombato; S M Aloj
    Thyrotropin regulation of membrane lipid fluidity in the FRTL-5 thyroid cell line. Its relationship to cell growth and functional activity.
    The Journal of biological chemistry 1987;262(4):1575-82.
  • 1985: M Bifulco; H A Saroff; L D Kohn; S M Aloj
    Thyrotropin interaction with high-density lipoproteins.
    Biochimica et biophysica acta 1985;835(2):191-200.
Register to see more